| 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis PC Grayson, C Ponte, R Suppiah, JC Robson, A Craven, A Judge, ... Arthritis & Rheumatology 74 (3), 386-392, 2022 | 442* | 2022 |
| Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials J Robson, H Doll, R Suppiah, O Flossmann, L Harper, P Höglund, ... Annals of the rheumatic diseases 74 (1), 177-184, 2015 | 320 | 2015 |
| ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS) A Craven, J Robson, C Ponte, PC Grayson, R Suppiah, A Judge, R Watts, ... Clinical and experimental nephrology 17, 619-621, 2013 | 234 | 2013 |
| 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis R Suppiah, JC Robson, PC Grayson, C Ponte, A Craven, S Khalid, ... Arthritis & Rheumatology 74 (3), 400-406, 2022 | 216 | 2022 |
| A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis R Suppiah, A Judge, R Batra, O Flossmann, L Harper, P Hoeglund, ... Arthritis Care & Research 63 (4), 588-596, 2011 | 195 | 2011 |
| 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis C Ponte, PC Grayson, JC Robson, R Suppiah, KB Gribbons, A Judge, ... Annals of the Rheumatic Diseases 81 (12), 1647-1653, 2022 | 183 | 2022 |
| Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials J Robson, H Doll, R Suppiah, O Flossmann, L Harper, P Höglund, ... Rheumatology 54 (3), 471-481, 2015 | 169 | 2015 |
| A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis R Suppiah, C Mukhtyar, O Flossmann, F Alberici, B Baslund, R Batra, ... Rheumatology 50 (5), 899-905, 2011 | 136 | 2011 |
| The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis PA Merkel, SZ Aydin, M Boers, H Direskeneli, K Herlyn, P Seo, R Suppiah, ... The Journal of rheumatology 38 (7), 1480-1486, 2011 | 135 | 2011 |
| Nomenclature and classification of vasculitis–update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS) RA Luqmani, R Suppiah, PC Grayson, PA Merkel, R Watts Clinical & Experimental Immunology 164 (Supplement_1), 11-13, 2011 | 133 | 2011 |
| Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials R Suppiah, RDM Hadden, R Batra, NK Arden, MP Collins, L Guillevin, ... Rheumatology 50 (12), 2214-2222, 2011 | 130 | 2011 |
| Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? B Seeliger, J Sznajd, JC Robson, A Judge, A Craven, PC Grayson, ... Rheumatology 56 (7), 1154-1161, 2017 | 114 | 2017 |
| Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda H Direskeneli, SZ Aydin, TA Kermani, EL Matteson, M Boers, K Herlyn, ... The Journal of rheumatology 38 (7), 1471-1479, 2011 | 107 | 2011 |
| Patterns of arterial disease in Takayasu arteritis and giant cell arteritis KB Gribbons, C Ponte, S Carette, A Craven, D Cuthbertson, GS Hoffman, ... Arthritis care & research 72 (11), 1615-1624, 2020 | 103 | 2020 |
| 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis PC Grayson, C Ponte, R Suppiah, JC Robson, KB Gribbons, A Judge, ... Arthritis & Rheumatology 74 (12), 1872-1880, 2022 | 100 | 2022 |
| Mortality in Wegener’s granulomatosis: a bimodal pattern R Luqmani, R Suppiah, CJ Edwards, R Phillip, J Maskell, D Culliford, ... Rheumatology 50 (4), 697-702, 2011 | 94 | 2011 |
| Systemic vasculitis—is it time to reclassify? RA Watts, R Suppiah, PA Merkel, R Luqmani Rheumatology 50 (4), 643-645, 2011 | 66 | 2011 |
| Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index R Suppiah, O Flossman, C Mukhtyar, F Alberici, B Baslund, D Brown, ... Annals of the rheumatic diseases 70 (1), 80-85, 2011 | 62 | 2011 |
| High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors R Suppiah, A Dissanayake, N Dalbeth The New Zealand Medical Journal (Online) 121 (1283), 2008 | 57 | 2008 |
| Diagnostic assessment strategies and disease subsets in giant cell arteritis: data from an international observational cohort KB Gribbons, C Ponte, A Craven, JC Robson, R Suppiah, R Luqmani, ... Arthritis & Rheumatology 72 (4), 667-676, 2020 | 44 | 2020 |
